A detailed history of American Capital Advisory, LLC transactions in Helius Medical Technologies, Inc. stock. As of the latest transaction made, American Capital Advisory, LLC holds 1,601 shares of HSDT stock, worth $1,376. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,601
Holding current value
$1,376
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$4.42 - $8.09 $7,076 - $12,952
1,601 New
1,601 $408,000

Others Institutions Holding HSDT

# of Institutions
1
Shares Held
1.6K
Call Options Held
0
Put Options Held
0

About HELIUS MEDICAL TECHNOLOGIES, INC.


  • Ticker HSDT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,197,200
  • Market Cap $24.2M
  • Description
  • Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...
More about HSDT
Track This Portfolio

Track American Capital Advisory, LLC Portfolio

Follow American Capital Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Advisory, LLC with notifications on news.